Clinical Trials on Post-transplant Lymphoproliferative Disease in Sweden
Total 390 results
-
Janssen Research & Development, LLCPharmacyclics LLC.Active, not recruitingLymphoma, Mantle-CellTaiwan, Thailand, Malaysia, India, Puerto Rico, Spain, Turkey, Czechia, Brazil, Greece, Poland, Sweden, Romania
-
AstraZenecaCompletedRelapsed/Refractory Peripheral T-cell Lymphoma | Relapsed/Refractory Classical Hodgkins LymphomaItaly, Sweden, United States, Taiwan, Korea, Republic of, United Kingdom, Australia, France, Singapore
-
Merck Sharp & Dohme LLCRecruitingMelanoma | Lymphoma | Solid Tumor | Classical Hodgkin Lymphoma | Microsatellite-instability-high Solid TumorFrance, Germany, Italy, Netherlands, Sweden, United Kingdom, Brazil, Israel, Korea, Republic of, United States
-
Hoffmann-La RocheRecruitingLymphomaKorea, Republic of, United States, Spain, France, Brazil, China, Canada, Australia, Sweden, Taiwan, Italy, United Kingdom
-
German CLL Study GroupCompletedChronic Lymphocytic LeukemiaGermany, Austria
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Genzyme, a Sanofi CompanyCompletedB-Cell Chronic Lymphocytic LeukemiaSweden, United States, Croatia, Canada, Ukraine, Austria, Bulgaria, France, Germany, Greece, Italy, Poland, Portugal, Romania, Russian Federation
-
Stichting Hemato-Oncologie voor Volwassenen NederlandNordic CLL Study GroupActive, not recruitingChronic Lymphocytic Leukemia in Relapse | Chronic Lymphocytic Leukemia in RemissionNetherlands, Belgium, Denmark, Finland, Norway, Sweden
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaBelgium, Italy, Spain, United States, Canada, Sweden, Greece, Netherlands, Austria, Switzerland, Poland, Turkey, Croatia, Brazil, Argentina, Denmark, United Kingdom
-
CelgeneTerminatedMultiple MyelomaUnited States, Canada, Spain, Italy, Denmark, United Kingdom, Belgium, Sweden, Germany
-
Hoffmann-La RocheCompletedLymphoma, FollicularSpain, Sweden, Canada, Mexico, Czech Republic, France, Switzerland, Australia, Israel, Korea, Republic of, United Kingdom, Italy, Brazil, Finland, Russian Federation, Peru, Denmark, Argentina, Poland, Ecuador, Norway, Slovakia
-
Janssen-Cilag G.m.b.HCompleted
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
Prof. Dr. M. Dreyling (co-chairman)ClinAssess GmbH; Klinikum der Universitaet Muenchen, Grosshadern; GELARC Service...UnknownMantle Cell LymphomaFrance, Germany
-
European Organisation for Research and Treatment...NCIC Clinical Trials Group; Nordic Lymphoma Group; Lymphoma Trials Office; Australasian... and other collaboratorsCompletedLymphomaFrance, Netherlands, Spain, Canada, Belgium, Australia, Sweden, United Kingdom, New Zealand, Hungary, Croatia, Czechia, Poland
-
Miltenyi Biomedicine GmbHICON plcRecruitingDiffuse Large B-cell LymphomaSpain, Germany, Netherlands, Belgium, France, Czechia, Austria, Lithuania, Sweden, Hungary, Italy, Poland
-
Prof. Dr. M. Dreyling (co-chairman)LMU KlinikumRecruitingMantle Cell LymphomaGermany, Sweden, Denmark, Italy, Norway
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
-
Incyte CorporationActive, not recruitingLymphomaUnited States, Spain, Italy, Israel, Poland, United Kingdom, Canada, Czechia, Germany, Denmark, Australia, Hungary, Sweden
-
German High-Grade Non-Hodgkin's Lymphoma Study...CompletedLymphomaGermany, Switzerland
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaItaly, Brazil, Slovenia, Spain, Germany, Switzerland, Russian Federation, Israel, Sweden, Albania, Argentina, Australia, Bosnia and Herzegovina, Bulgaria, Colombia, Croatia, Ecuador, Egypt, Finland, Greece, Mexico, Romania, Slovakia, ...
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedAggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced NeutropeniaGermany, Italy, Spain
-
Merck Sharp & Dohme LLCRecruitingHodgkin LymphomaAustralia, Israel, Korea, Republic of, Spain, Poland, Sweden, United Kingdom, Turkey, China, United States, Brazil, Germany, Belgium, France, Switzerland, Canada, Czechia, Chile, Argentina
-
German CLL Study GroupUniversity of CologneCompletedChronic Lymphocytic LeukemiaGermany
-
University of GiessenRecruiting
-
EBMT Solid Tumors Working PartyLymphoma Trials OfficeCompletedLymphomaFrance, Spain, United Kingdom, Australia, Israel, Poland, Belgium, Switzerland, Canada, Germany, Denmark, New Zealand, Austria, Portugal, Turkey, Czech Republic, Sweden
-
International Extranodal Lymphoma Study Group (IELSG)Active, not recruitingPrimary Mediastinal B-cell LymphomaNorway, United Kingdom, Italy, Switzerland, Czechia, United States, China, Argentina, Canada, Germany, Poland, Portugal, Sweden, Ukraine
-
Oncopeptides ABTerminatedRelapsed Multiple Myeloma | Relapsed-Refractory Multiple MyelomaSerbia, Greece, Russian Federation, Czechia, Bulgaria, Georgia, Norway, Poland, Spain, Ukraine, Germany
-
Hoffmann-La RocheRoche Pharma AGTerminatedMultiple MyelomaGermany
-
CelgeneCompletedLymphoma, Non-HodgkinUnited States, Belgium, Germany, Japan, Netherlands, France, Sweden, Italy, Spain, Switzerland, United Kingdom, Finland
-
PfizerCompletedLymphomaCanada, United States, Spain, Austria, Poland, Sweden, China, Belgium, France, Germany, Italy, United Kingdom, Netherlands, Argentina, Switzerland, Chile, Australia, Brazil
-
CelgeneCompletedChronic Lymphocytic Leukemia | Leukemia, B-Cell, ChronicCanada, United States, Germany, Italy, Spain, Sweden, United Kingdom
-
German High-Grade Non-Hodgkin's Lymphoma Study...Completed
-
Kiadis PharmaTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States, Canada, Netherlands, Israel, Germany, United Kingdom, Belgium, Italy, Sweden, Croatia, Spain, France, Portugal
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicFinland, France, Spain, Portugal, Turkey, United Kingdom, Sweden, Tunisia
-
German CLL Study GroupAbbVie; Hoffmann-La Roche; Swiss Group for Clinical Cancer Research; Stichting... and other collaboratorsCompletedChronic Lymphocytic LeukemiaIreland, Germany, Israel, Austria, Belgium, Denmark, Switzerland, Finland, Sweden, Netherlands
-
CelgeneCompletedLymphoma, Mantle-Cell | Mantle Cell LymphomaFrance, United Kingdom, Belgium, Spain, Denmark, Germany, Israel, Russian Federation, Italy, Poland, Netherlands, Sweden, Greece, Czechia
-
Celgene CorporationCompletedRelapsed or Refractory Multiple MyelomaGermany
-
Incyte Biosciences International SàrlRecruitingLymphoma | Acute Myeloid Leukemia | Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Solid Tumors | Chronic Phase Chronic Myeloid Leukemia | Accelerated Phase Chronic Myeloid Leukemia | Blast Phase Chronic Myeloid LeukemiaSpain, Italy, France, Germany, United Kingdom, Belgium, Sweden, Denmark, Netherlands
-
BayerCompletedLymphoma, Non-HodgkinBelgium, France, Spain, Italy, Canada, Switzerland, Netherlands, United Kingdom, Portugal, Germany, Sweden, Denmark, Norway
-
Swedish Orphan BiovitrumRecruitingSystemic Lupus Erythematosus | Macrophage Activation Syndrome | Still Disease | Secondary Hemophagocytic Lymphohistiocytosis | SJIA | AOSD | MASUnited States, Belgium, Italy, Netherlands, United Kingdom, China, France, Spain, Czechia, Canada, Sweden, Japan, Germany, Poland
-
Nordic NanovectorICON Clinical ResearchCompletedFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Janssen Research & Development, LLCPharmacyclics LLC.TerminatedLymphoma, Non-HodgkinUnited States, France, Poland, United Kingdom, Germany, Taiwan, Spain, Bulgaria, Romania, Turkey, Ukraine, Canada, Korea, Republic of, Netherlands, Russian Federation, Belgium, Brazil, Hungary, Czechia, Sweden
-
CelgeneCompletedMultiple MyelomaSpain, United Kingdom, Switzerland, Australia, Israel, Italy, Poland, France, Belgium, Ireland, Austria, Germany, Ukraine, Greece, Sweden
-
AmgenCompletedMultiple MyelomaFrance, Poland, United Kingdom, Belgium, Germany, Spain, Israel, Serbia, Australia, Greece, Korea, Republic of, Russian Federation, Hungary, Sweden, Austria, Slovakia, Italy, Czechia, New Zealand
-
Eli Lilly and CompanyCompletedNon Hodgkin LymphomaUnited States, China, Spain, Poland, Taiwan, Belgium, Japan, Germany, Puerto Rico, Australia, France, Sweden, Greece, Italy, India, Czechia, United Kingdom, Canada, Korea, Republic of, Mexico, Denmark, Portugal, Finland, Brazil, Hungary
-
Genentech, Inc.Roche Pharma AGCompletedNon-Hodgkin's LymphomaUnited States, Spain, France, Canada, United Kingdom, Austria, Belgium, Czechia, Russian Federation, Italy, Switzerland, Germany, Netherlands, Sweden
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedMantle Cell LymphomaFrance, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Colombia, Portugal, Ukraine, Canada, Netherlands, Sweden, Korea, Republic of, Chile, Brazil, Russian Federation, Hungary, Ireland, Mexico, Czechia
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Belgium, Germany, Spain, Portugal, Greece, Austria, Luxembourg